Current role
Alastair Garfield
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alastair Garfield
The proxy statement of Rhythm Pharmaceuticals, Inc. reports total compensation of $4,427,024 for Alastair Garfield in fiscal 2025, including a base salary of $505,385.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Rhythm Pharmaceuticals, Inc. (RYTM)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rhythm Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- David P. Meeker, M.D. CEO, Chairman
- Hunter Smith CEO, CFO
- David Meeker Chairman
- Christophe R. Jean Board Member
- David W. J. McGirr Board Member
- Jennifer Good Board Member
- Kimberly J. Popovits Board Member
- Lynn A. Tetrault Board Member
- Stuart A. Arbuckle Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Scientific Officer | $505,385 | $4,427,024 |
Recent activity
No call appearances or filed executive changes recorded yet.